Avanos Medical, Inc.
AVNS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $732 | $1,045 | $1,269 | $1,668 |
| - Cash | $108 | $88 | $128 | $119 |
| + Debt | $170 | $209 | $277 | $188 |
| Enterprise Value | $795 | $1,167 | $1,418 | $1,737 |
| Revenue | $688 | $673 | $684 | $745 |
| % Growth | 2.2% | -1.6% | -8.1% | – |
| Gross Profit | $381 | $380 | $394 | $380 |
| % Margin | 55.4% | 56.4% | 57.6% | 51% |
| EBITDA | -$346 | $51 | $78 | $49 |
| % Margin | -50.2% | 7.5% | 11.4% | 6.6% |
| Net Income | -$392 | -$62 | $51 | $6 |
| % Margin | -57% | -9.2% | 7.4% | 0.8% |
| EPS Diluted | -8.53 | -1.33 | 1.07 | 0.13 |
| % Growth | -541.4% | -224.3% | 723.1% | – |
| Operating Cash Flow | $101 | $32 | $91 | $87 |
| Capital Expenditures | -$18 | -$18 | -$19 | -$21 |
| Free Cash Flow | $83 | $15 | $72 | $66 |